Metastatic Tumor clinical trials at University of California Health

1 in progress, 0 open to eligible people

NKT3447 for Adults With Advanced/Metastatic Solid Tumors
Sorry, in progress, not accepting new patients
The goal of the Dose Escalation phase of the study is to evaluate the safety, tolerability, and pharmacokinetics (PK) to determine the maximum tolerated dose (MTD) and/or preliminary recommended dose for expansion (RDE) of NKT3447 in adults with…
at UCSF

Last updated: March 6, 2025